Response-shift effects in neuromyelitis optica spectrum disorder: estimating response-shift-adjusted scores using equating

BACKGROUND: In our companion paper, random intercept models (RIMs) investigated response-shift effects in a clinical trial comparing Eculizumab to Placebo for people with neuromyelitis optica spectrum disorder (NMOSD). RIMs predicted Global Health using the EQ-5D Visual Analogue Scale item (VAS) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Carolyn E., Stark, Roland B., Stucky, Brian D., Li, Yuelin, Rapkin, Bruce D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068715/
https://www.ncbi.nlm.nih.gov/pubmed/33398520
http://dx.doi.org/10.1007/s11136-020-02727-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068715/
https://www.ncbi.nlm.nih.gov/pubmed/33398520
http://dx.doi.org/10.1007/s11136-020-02727-8

Ejemplares similares